PLAY PODCASTS
Ep. 533  “Under 60 or Else?” – The Dangerous Myth Limiting Women’s Hormone Therapy

Ep. 533 “Under 60 or Else?” – The Dangerous Myth Limiting Women’s Hormone Therapy

Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+ · Everyday Wellness™

December 25, 202517m 39s

Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

We have another AMA episode today, where I answer some of the most frequently asked podcast listener questions.

In response to a question from Catherine, we unpack the timing hypothesis in this episode, exploring the cardiovascular nuances and clarifying why individualized care truly matters.

IN THIS EPISODE, YOU WILL LEARN:

  • Cardiovascular and metabolic benefits of starting hormone therapy within about 10 years of menopause onset

  • What the timing hypothesis really means in clinical practice

  • Why feeling better does not necessarily imply long-term disease risk has been reduced

  • How endothelial (blood vessel) health influences the effectiveness of hormone therapy 

  • Why metabolic changes after menopause matter more than most women realize

  • How their hormone therapy decisions must change as women move further beyond menopause 

  • Risks and benefits of oral versus transdermal hormone delivery

  • Value of shared patient-clinician decision-making 

  • How lifestyle habits and risk assessment form the foundation for safe, effective, and personalized hormone therapy decisions

Connect with Cynthia Thurlow